Issovox Medtech
| Reference number | |
| Coordinator | Isovox Medtech AB |
| Funding from Vinnova | SEK 100 000 |
| Project duration | December 2018 - November 2019 |
| Status | Completed |
Important results from the project
The goal was to develop a strategy to protect our business in new markets. Together with AWA and Artex, we have succeeded in achieving this. We finally landed in an optimized IP protection, which will be protected through a number of protections throughout the world. This will strengthen our position in the market and protect our future sources of revenue.
Expected long term effects
We achieved a successful results with our IP effort. This is expected to result in the exclusive right to our products in the relevant industry.
Approach and implementation
Our plan during the process was to first review our portfolio of products, our customers´ needs and opportunities to develop them. to protect our business in the best possible way, without compromising on the quality of our products. After a lot of work we managed to get a solution that all parties are happy with.